Skip to content

Effects of Different Anesthetic Drugs on Anesthesiologists' Heart Rate Variability During Anesthesia : A Pilot Study

Effects of Different Anesthetic Drugs on Anesthesiologists' Heart Rate Variability During Anesthesia: A Randomized, Controlled, Double-Blind Trial Protocol

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112306
Enrollment
Unknown
Registered
2025-11-12
Start date
2025-11-18
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrhythmia

Interventions

Experimental group:Induction of painless gastroscopy anesthesia using ciprofol
Control group:Induction of painless gastroscopy anesthesia using propofol

Sponsors

Tacheng Prefecture People's Hospital of Ili Kazakh Autonomous Prefecture
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Anesthesiologists must have a valid practice certificate and be qualified to perform painless gastroscopy anesthesia; 2.Anesthesiologists and patients must cooperate to complete the entire trial and sign the informed consent; 3.Patients aged between 18 and 65 years, inclusive; 4.Patient body mass index (BMI) between 18.5–30 kg/m^2; 5.Patients classified as ASA class I–II, indicating no significant underlying diseases; 6.Patients have no visual, auditory, language, or communication impairments.

Exclusion criteria

Exclusion criteria: 1.Anesthesiologists with underlying diseases affecting heart rate variability (HRV) within the past 3 months (e.g., severe arrhythmia, hypertension, other cardiovascular diseases, metabolic diseases, neurological diseases, and others); 2.Anesthesiologists who have used drugs affecting HRV within the past 2 weeks [9] (e.g., cardiovascular drugs, antidepressants, etc.); 3.Anesthesiologists who are long-term smokers, alcohol abusers, or caffeine-dependent individuals (daily intake exceeding 300 mg caffeine); 4.Anesthesiologists with sleep disorders in the past month (e.g., insomnia, daily sleep less than 6 hours); 5.Patients who refuse to continue participation in the study; 6.Patients with allergies to anesthetic drugs; 7.Patients with a history of respiratory system diseases; 8.Patients with uncontrolled clinically significant liver, kidney, hematological, neurological, or metabolic system diseases, as judged by the investigator to be unsuitable for participation; 9.Patients who require rescue or general anesthesia with intubation during gastroscopy; 10.Patients with difficult airways; 11.Pregnant or lactating women; 12.Any other participants deemed unsuitable for the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Root Mean Square of Successive Differences;

Secondary

MeasureTime frame
Standard Deviation of NN interyals;Standard Deviation of Average NN intervals;Standard Deviation of Successive Differences;Percentage of successive NN intervals that differ by more than 50 ms;Triangular Index of NN intervals;High Frequency power;Low Frequency power;Very Low Frequency power;Ultra Low Frequency power;LF to HF Ratio;

Countries

China

Contacts

Public ContactCui Zhifeng

Tacheng Prefecture People's Hospital of Ili Kazakh Autonomous Prefecture

18709011952@163.com+86 901 627 8957

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026